Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Worldwide Revenue ($M) ($M)
Medtronic Form 8-K Quarterly World-Wide Revenue Tables & Form 10-K/10-Q Segment Disclosures
Latest, FY2026
2,068
Period ended Apr 30, 2026
Change on a year earlier
+7.0%
1,932 in FY2025
History
9 years
Since FY2015
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Worldwide Revenue ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2026 | Apr 30, 2026 | 2,068 | +7.0% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2025 | Apr 30, 2025 | 1,932 | +10.7% | Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗ |
| FY2024 | Apr 30, 2024 | 1,746 | +3.1% | Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗ |
| FY2023 | Apr 30, 2023 | 1,693 | -2.4% | Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗ |
| FY2022 | Apr 30, 2022 | 1,735 | +8.4% | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2021 | Apr 30, 2021 | 1,601 | +6.9% | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2020 | Apr 30, 2020 | 1,497 | -13.8% | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2019 | Apr 30, 2019 | 1,736 | – | Medtronic Form 10-K — FY2021 (filed 2021-06-25) ↗ |
| FY2015 | Apr 30, 2015 | 3 | – | Medtronic SEC 8K_EARNINGS — FY2016Q4 (filed 2016-05-31) ↗ |
Breakdown
What makes up neuromodulation (pain stim, brain modulation & drug pumps) — worldwide revenue ($m)
- Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Organic Revenue Growth YoY (%)5.2% · FY2026
- Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Foreign Currency Impact ($M)36 · FY2026
- Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Reported Revenue Growth YoY (%)7.0% · FY2026
- Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — U.S. Revenue ($M)1,376 · FY2026
- Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — International Revenue ($M)692 · FY2026
Cite this data
StockData. (2026). Medtronic Neuromodulation (Pain Stim, Brain Modulation & Drug Pumps) — Worldwide Revenue ($M) ($M), annual FY2015–FY2026 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/neuro-nm-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.